Siren Biotechnology

📍 San Francisco, United States👥 11 employees💰 Last funded May 2025
Biotechnology Research🌐 sirenbiotechnology.com
Website LinkedIn
The fight against cancer needs new, big, bold ideas. At Siren, we’ve got one: Universal AAV Immuno-Gene Therapy. We are combining two transformative therapeutic technologies – AAV gene therapy and cytokine immunotherapy - into a single, reimagined modality that overcomes key challenges and redefines how we destroy tumor cells and elicit anti-tumor immunity.
4
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded

Investors

4 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
United States
3
Indonesia
1
Investor activity2023–2025 · investors recorded per year
2023220252
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Siren Biotechnology?
Siren Biotechnology has 4 investors on record on gritt.io.
When did Siren Biotechnology last raise funding?
The most recent investment in Siren Biotechnology recorded on gritt.io was in May 2025.
What industry is Siren Biotechnology in?
Siren Biotechnology operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Siren Biotechnology based?
Siren Biotechnology is headquartered in San Francisco, United States.